Vivodyne, which uses AI and robots to grow human tissues in the lab for drug discovery and development, raised a $40M Series A led by Khosla Ventures (Katherine Davis/Axios)

Katherine Davis / Axios: Vivodyne, which uses AI and robots to grow human tissues in the lab for drug discovery and development, raised a $40M Series A led by Khosla Ventures  —  Vivodyne, a San Francisco-based startup using lab-grown human tissues to discover and develop drugs, raised $40 million in a Series A led by Khosla Ventures.

May 31, 2025 - 17:30
 0
Vivodyne, which uses AI and robots to grow human tissues in the lab for drug discovery and development, raised a $40M Series A led by Khosla Ventures (Katherine Davis/Axios)

Katherine Davis / Axios:
Vivodyne, which uses AI and robots to grow human tissues in the lab for drug discovery and development, raised a $40M Series A led by Khosla Ventures  —  Vivodyne, a San Francisco-based startup using lab-grown human tissues to discover and develop drugs, raised $40 million in a Series A led by Khosla Ventures.